A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice.

Breast / diagnostic imaging Breast Neoplasms / diagnostic imaging Diffusion Magnetic Resonance Imaging / methods Female Humans Magnetic Resonance Imaging / methods Sensitivity and Specificity Surveys and Questionnaires
Breast neoplasms Magnetic resonance imaging Surveys and questionnaires

Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 31 12 2021
accepted: 21 04 2022
revised: 19 04 2022
pubmed: 5 5 2022
medline: 17 9 2022
entrez: 4 5 2022
Statut: ppublish

Résumé

To perform a survey among all European Society of Breast Imaging (EUSOBI) radiologist members to gather representative data regarding the clinical use of breast DWI. An online questionnaire was developed by two board-certified radiologists, reviewed by the EUSOBI board and committees, and finally distributed among EUSOBI active and associated (not based in Europe) radiologist members. The questionnaire included 20 questions pertaining to technical preferences (acquisition time, magnet strength, breast coils, number of b values), clinical indications, imaging evaluation, and reporting. Data were analyzed using descriptive statistics, the Chi-square test of independence, and Fisher's exact test. Of 1411 EUSOBI radiologist members, 275/1411 (19.5%) responded. Most (222/275, 81%) reported using DWI as part of their routine protocol. Common indications for DWI include lesion characterization (using an ADC threshold of 1.2-1.3 × 10 The utilization of DWI in clinical practice among EUSOBI radiologists who responded to the survey is generally in line with international recommendations, with the main application being the differentiation of benign and malignant enhancing lesions, treatment response assessment, and prediction of response to chemotherapy. Report integration of qualitative and quantitative DWI data is not uniform. • Clinical performance of breast DWI is in good agreement with the current recommendations of the EUSOBI International Breast DWI working group. • Breast DWI applications in clinical practice include the differentiation of benign and malignant enhancing, treatment response assessment, and prediction of response to chemotherapy. • Report integration of DWI results is not uniform.

Identifiants

DOI: 10.1007/s00330-022-08833-0 PMID: 35507050 PMC: PMC9064723
pubmed: 35507050
doi: 10.1007/s00330-022-08833-0
pii: 10.1007/s00330-022-08833-0
pmc: PMC9064723
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6588-6597

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB017183
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Références

Mann RM, Kuhl CK, Moy L (2019) Contrast-enhanced MRI for breast cancer screening. J Magn Reson Imaging 50:377–390
pubmed: 30659696 pmcid: 6767440 doi: 10.1002/jmri.26654
Pinker K, Bickel H, Helbich TH et al (2013) Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions. Eur Radiol 23:1791–1802
pubmed: 23504036 doi: 10.1007/s00330-013-2771-8
Rahbar H, Zhang Z, Chenevert TL et al (2019) Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin Cancer Res 25:1756–1765
pubmed: 30647080 pmcid: 6420847 doi: 10.1158/1078-0432.CCR-18-2967
Spick C, Pinker-Domenig K, Rudas M, Helbich TH, Baltzer PA (2014) MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol 24:1204–1210
pubmed: 24706105 doi: 10.1007/s00330-014-3153-6
Baltzer A, Dietzel M, Kaiser CG, Baltzer PA (2016) Combined reading of contrast enhanced and diffusion weighted magnetic resonance imaging by using a simple sum score. Eur Radiol 26:884–891
pubmed: 26115653 doi: 10.1007/s00330-015-3886-x
Woodhams R, Matsunaga K, Iwabuchi K et al (2005) Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 29:644–649
pubmed: 16163035 doi: 10.1097/01.rct.0000171913.74086.1b
Woodhams R, Matsunaga K, Kan S et al (2005) ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4:35–42
pubmed: 16127252 doi: 10.2463/mrms.4.35
Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M (2006) Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 24:319–324
pubmed: 16786565 doi: 10.1002/jmri.20643
Wenkel E, Geppert C, Schulz-Wendtland R et al (2007) Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 14:1077–1083
pubmed: 17707315 doi: 10.1016/j.acra.2007.06.006
Baltzer PA, Renz DM, Herrmann KH et al (2009) Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 19:1612–1620
pubmed: 19288109 doi: 10.1007/s00330-009-1326-5
Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 193:1716–1722
pubmed: 19933670 doi: 10.2214/AJR.08.2139
Chen X, Li WL, Zhang YL, Wu Q, Guo YM, Bai ZL (2010) Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer 10:693
pubmed: 21189150 pmcid: 3024311 doi: 10.1186/1471-2407-10-693
Dorrius MD, Dijkstra H, Oudkerk M, Sijens PE (2014) Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol 24:2835–2847
pubmed: 25103535 doi: 10.1007/s00330-014-3338-z
Shi RY, Yao QY, Wu LM, Xu JR (2018) Breast lesions: diagnosis using diffusion weighted imaging at 1.5T and 3.0T-systematic review and meta-analysis. Clin Breast Cancer 18:e305–e320
pubmed: 28802529 doi: 10.1016/j.clbc.2017.06.011
Iima M, Kataoka M, Kanao S et al (2018) Intravoxel incoherent motion and quantitative non-Gaussian diffusion MR imaging: evaluation of the diagnostic and prognostic value of several markers of malignant and benign breast lesions. Radiology 287:432–441
pubmed: 29095673 doi: 10.1148/radiol.2017162853
Iima M, Yano K, Kataoka M et al (2015) Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions. Invest Radiol 50:205–211
pubmed: 25260092 doi: 10.1097/RLI.0000000000000094
Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843–847
pubmed: 16916701 doi: 10.1016/j.mri.2005.11.005
Richard R, Thomassin I, Chapellier M et al (2013) Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 23:2420–2431
pubmed: 23652844 doi: 10.1007/s00330-013-2850-x
Galbán CJ, Ma B, Malyarenko D et al (2015) Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy. PLoS One 10:e0122151
pubmed: 25816249 pmcid: 4376686 doi: 10.1371/journal.pone.0122151
Li X, Abramson RG, Arlinghaus LR et al (2015) Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Invest Radiol 50:195–204
pubmed: 25360603 pmcid: 4471951 doi: 10.1097/RLI.0000000000000100
Leong KM, Lau P, Ramadan S (2015) Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy. J Med Imaging Radiat Oncol 59:268–277
pubmed: 25913106 doi: 10.1111/1754-9485.12310
Partridge SC, Zhang Z, Newitt DC et al (2018) Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: The ACRIN 6698 Multicenter Trial. Radiology 289:618–627
pubmed: 30179110 doi: 10.1148/radiol.2018180273
Newitt DC, Zhang Z, Gibbs JE et al (2019) Test-retest repeatability and reproducibility of ADC measures by breast DWI: results from the ACRIN 6698 trial. J Magn Reson Imaging 49:1617–1628
pubmed: 30350329 doi: 10.1002/jmri.26539
Amornsiripanitch N, Bickelhaupt S, Shin HJ et al (2019) Diffusion-weighted MRI for unenhanced breast cancer screening. Radiology 293:504–520
pubmed: 31592734 doi: 10.1148/radiol.2019182789
Baltzer P, Mann RM, Iima M et al (2020) Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 30:1436–1450
pubmed: 31786616 doi: 10.1007/s00330-019-06510-3
Trimboli RM, Capra D, Codari M, Cozzi A, Di Leo G, Sardanelli F (2021) Breast arterial calcifications as a biomarker of cardiovascular risk: radiologists' awareness, reporting, and action. A survey among the EUSOBI members. Eur Radiol 31:958–966
pubmed: 32851451 doi: 10.1007/s00330-020-07136-6
Clauser P, Mann R, Athanasiou A et al (2018) A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice. Eur Radiol 28:1909–1918
pubmed: 29168005 doi: 10.1007/s00330-017-5121-4
Baxter GC, Graves MJ, Gilbert FJ, Patterson AJ (2019) A meta-analysis of the diagnostic performance of diffusion MRI for breast lesion characterization. Radiology 291:632–641
pubmed: 31012817 doi: 10.1148/radiol.2019182510
Hargreaves BA, Daniel B (2021) Abbreviated non-contrast-enhanced mri for breast cancer screening (R01CA249893). National Cancer Institute, Stanford University
Tamura T, Murakami S, Naito K, Yamada T, Fujimoto T, Kikkawa T (2014) Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI. Cancer Imaging 14:11
pubmed: 25608450 pmcid: 4331817 doi: 10.1186/1470-7330-14-11
Park JH, Yun B, Jang M et al (2019) Comparison of the diagnostic performance of synthetic versus acquired high b-value (1500 s/mm(2) ) diffusion-weighted MRI in women with breast cancers. J Magn Reson Imaging 49:857–863
pubmed: 30129695 doi: 10.1002/jmri.26259
Bickelhaupt S, Laun FB, Tesdorff J et al (2016) Fast and noninvasive characterization of suspicious lesions detected at breast cancer X-ray screening: capability of diffusion-weighted MR imaging with MIPs. Radiology 278:689–697
pubmed: 26418516 doi: 10.1148/radiol.2015150425
Bickelhaupt S, Paech D, Kickingereder P et al (2017) Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography. J Magn Reson Imaging 46:604–616
pubmed: 28152264 doi: 10.1002/jmri.25606
Stadlbauer A, Bernt R, Gruber S et al (2009) Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol 19:2349–2356
pubmed: 19415286 doi: 10.1007/s00330-009-1426-2
Daimiel Naranjo I, Lo Gullo R, Saccarelli C et al (2021) Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI. Eur Radiol 31:356–367
pubmed: 32780207 doi: 10.1007/s00330-020-07094-z
Choi BH, Baek HJ, Ha JY et al (2020) Feasibility study of synthetic diffusion-weighted MRI in patients with breast cancer in comparison with conventional diffusion-weighted MRI. Korean J Radiol 21:1036–1044
pubmed: 32691539 pmcid: 7371621 doi: 10.3348/kjr.2019.0568
Bickel H, Polanec SH, Wengert G et al (2019) Diffusion-weighted MRI of breast cancer: improved lesion visibility and image quality using synthetic b-values. J Magn Reson Imaging 50:1754–1761
pubmed: 31136044 pmcid: 6899592 doi: 10.1002/jmri.26809
Shin HJ, Lee SH, Park VY et al (2021) Diffusion-weighted magnetic resonance imaging for breast cancer screening in high-risk women: design and imaging protocol of a prospective multicenter study in Korea. J Breast Cancer 24:218–228
pubmed: 33913277 pmcid: 8090809 doi: 10.4048/jbc.2021.24.e19
Kul S, Metin Y, Kul M, Metin N, Eyuboglu I, Ozdemir O (2018) Assessment of breast mass morphology with diffusion-weighted MRI: beyond apparent diffusion coefficient. J Magn Reson Imaging 48:1668–1677
pubmed: 29734493 doi: 10.1002/jmri.26175
Radovic N, Ivanac G, Divjak E, Biondic I, Bulum A, Brkljacic B (2019) Evaluation of breast cancer morphology using diffusion-weighted and dynamic contrast-enhanced MRI: intermethod and interobserver agreement. J Magn Reson Imaging 49:1381–1390
pubmed: 30325549 doi: 10.1002/jmri.26332
Clauser P, Krug B, Bickel H et al (2021) Diffusion-weighted imaging allows for downgrading MR BI-RADS 4 lesions in contrast-enhanced MRI of the breast to avoid unnecessary biopsy. Clin Cancer Res 27:1941–1948
pubmed: 33446565 pmcid: 8406278 doi: 10.1158/1078-0432.CCR-20-3037
D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA (2013) ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. American College of Radiology, Reston

Auteurs

Roberto Lo Gullo (R)

Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY, 10065, USA.

Varadan Sevilimedu (V)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Ave, NY, New York, 10017, USA.

Pascal Baltzer (P)

Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Structural Preclinical Imaging, Medical University of Vienna/Vienna General Hospital, Wien, Austria.

Denis Le Bihan (D)

NeuroSpin/Joliot, CEA-Saclay Center, Paris-Saclay University, Gif-sur-Yvette, France.
Human Brain Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
National Institute for Physiological Sciences, Okazaki, Japan.

Julia Camps-Herrero (J)

Ribera Salud Hospitals, Valencia, Spain.

Paola Clauser (P)

Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Structural Preclinical Imaging, Medical University of Vienna/Vienna General Hospital, Wien, Austria.

Fiona J Gilbert (FJ)

Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Mami Iima (M)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Kyoto, Japan.

Ritse M Mann (RM)

Department of Diagnostic Imaging, Radboud University Medical Centre, Nijmegen, Netherlands.
Department of Radiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

Savannah C Partridge (SC)

Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA.

Andrew Patterson (A)

Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Eric E Sigmund (EE)

Department of Radiology, NYU Langone Health, 6, 60 1st Avenue, New York, NY, 10016, USA.

Sunitha Thakur (S)

Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY, 10065, USA.
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY, 10065, USA.

Fabienne E Thibault (FE)

Department of Medical Imaging, Institut Curie, 26 Rue d'Ulm, F-75005, Paris, France.

Laura Martincich (L)

Unit of Radiodiagnostics, Ospedale Cardinal G. Massaia -ASL AT, Via Conte Verde 125, 14100, Asti, Italy.

Katja Pinker (K)

Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY, 10065, USA. pinkerdk@mskcc.org.
Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Structural Preclinical Imaging, Medical University of Vienna/Vienna General Hospital, Wien, Austria. pinkerdk@mskcc.org.
ORCID: 0000-0002-2722-7331

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions du corps › Région mammaire › A survey by the European Society of Breast...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › A survey by the European Society of Breast...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Imagerie par résonance magnétique de diffusion › A survey by the European Society of Breast...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A survey by the European Society of Breast...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › A survey by the European Society of Breast...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Sensibilité et spécificité › A survey by the European Society of Breast...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › A survey by the European Society of Breast...